Labshake search
Citations for Tocris :
501 - 550 of 771 citations for 6 CHLORO 3 METHYLPYRIDO 3 4 D PYRIMIDIN 4 3H ONE since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2020Quote: ... to isolate inner retinal signaling (B-waves) and DL-2-Amino-4-phosphonobutyric acid (DL-AP4, 40µM, Tocris Bioscience, Bristol, U.K.) to isolate the photoreceptor component of the ERG signal (A-wave) ...
-
bioRxiv - Developmental Biology 2019Quote: ... From day 2 to day 4 the medium was additionally supplemented with BMP and TGFβ inhibitors (Noggin, Peprotech and SB431542, Tocris Bioscience). Treatment with MEK inhibitor (PD184352 ...
-
bioRxiv - Neuroscience 2020Quote: ... ACSF of similar composition to the normal ACSF but with increased concentration (4 mM) of MgCl2 and CaCl2 and supplemented with 100μM MNI-caged glutamate (Tocris Bioscience, UK) for glutamate uncaging experiments ...
-
bioRxiv - Neuroscience 2022Quote: ... where they were immobilized under a nylon mesh (Smart Ephys, SHD-26GH/10) and paralyzed by injecting 0.5 nL of bungarotoxin at 0.5 mM (Tocris, #110.32-79-4) in the trunk musculature ...
-
bioRxiv - Neuroscience 2023Quote: ... the α7 nAChR specific agonist PNU 282987 (1.6 μg total dose; 0.2 μL volume of 4 μg/μL per side; PNU 282987, Tocris, Ellisville, MO, USA), or vehicle (artificial cerebrospinal fluid [aCSF] or 50/50% aCSF/dimethylsulfoxide [DMSO] ...
-
bioRxiv - Neuroscience 2023Quote: ... Firing rates of individual channels were compared before and after treatment with potassium channel blocker 4-AP (50 μM; Tocris, 0940), sodium channel blocker TTX (1 μM ...
-
bioRxiv - Neuroscience 2021Quote: ... 25 μM of d-(-)-2-amino-5-phosphonopentanoic acid (D-AP5, 0106, Tocris Bioscience, UK), and 10 μM of SR95531 (SR ...
-
bioRxiv - Neuroscience 2019Quote: ... D-2-amino-5-phosphonovalerate (“D-AP5”, 50 mM in PBS, Tocris Cat No 0106); Retigabine (100 mM in DMSO ...
-
bioRxiv - Developmental Biology 2022Quote: ... and 1% Pen/Strep) +2iLIF (10 ng/ml leukemia inhibitory factor + 3 μM CHIR99021 + 1 μM PD0325901 from Tocris, Cat. # 4423 and 4192, respectively). The cells were grown on 0.1% gelatin-coated dishes and usually seeded at a density of 0.5–1.5 × 104/cm2 ...
-
bioRxiv - Neuroscience 2020Quote: ... 250 nM PACAP 6-38 (Tocris), 20 µM Bicuculline (Cayman chemical) ...
-
bioRxiv - Neuroscience 2019Quote: ... 6-OHDA (Tocris; conjugated with HBr) was injected bilaterally in a 4 × 3 grid at AP coordinates 5.1 ...
-
bioRxiv - Pharmacology and Toxicology 2019Quote: ... The P2Y2R antagonist AR-C118925XX (5-[[5-(2,8-Dimethyl-5H-dibenzo[a,d]cyclohepten-5-yl)-3,4-dihydro-2-oxo-4-thioxo-1(2H)-pyrimidinyl]methyl]-N-2H-tetrazol-5-yl-2-furancarboxamide) was obtained from Tocris (Abingdon, UK). Subsequent dilutions of receptor ligand and other reagents were made in Krebs-Ringer Glucose phosphate buffer (KRG ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... as well as the P2Y2R antagonist AR-C118925XX (5-[[5-(2,8-Dimethyl-5H-dibenzo[a,d]cyclohepten-5-yl)-3,4-dihydro-2-oxo-4-thioxo-1(2H)-pyrimidinyl]methyl]-N-2H-tetrazol-5-yl-2-furancarboxamide) were obtained from Tocris (Abingdon, UK). Subsequent dilutions of receptor ligand and other reagents were made in Krebs-Ringer Glucose phosphate buffer (KRG ...
-
bioRxiv - Neuroscience 2023Quote: ... was selected by qualifying the presence of innervated cancer spheroids at various heights within the gel layer before stimulation with either 4 µM Bradykinin (Tocris/Biotechne, #3004) or 1 µM Capsaicin (Tocris/Biotechne ...
-
bioRxiv - Developmental Biology 2021Quote: ... (S)-(+)-Dimethindenemaleate (D, 1 mM; Tocris, 1425) and Minocycline hydrochloride (M ...
-
bioRxiv - Neuroscience 2021Quote: ... D-amphetamine (in sulfate formulation; Tocris) was used at 4mg/kg (31) ...
-
bioRxiv - Neuroscience 2022Quote: ... and 50 μM D-AP5 (Tocris) in the bath solution ...
-
bioRxiv - Physiology 2023Quote: ... For [D-Ala2]-GIP (6699, Tocris), mice were injected with a single dose of [D-Ala2]-GIP (0.1 μg ...
-
bioRxiv - Developmental Biology 2024Quote: ... 2.5 µM Y27632 (R&D/Tocris), 25 ng/mL rhEGF (R&D/Tocris) ...
-
Autism genes converge on microtubule biology and RNA-binding proteins during excitatory neurogenesisbioRxiv - Systems Biology 2024Quote: ... 10uM DAPT (D)(Tocris, Cat#2634). Media was refreshed every three days ...
-
bioRxiv - Neuroscience 2024Quote: ... and D-APV (50 μM, Tocris), to selectively block glutamatergic signalling ...
-
bioRxiv - Neuroscience 2020Quote: ... we injected one of two doses of synthetic oxytocin (Tocris) into the BNSTam of females and males naïve to stress ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... [D-Pen2,D-Pen5]Enkephalin (DPDPE) and racemic U-50,488 HCl were purchased from Tocris (Minneapolis, MN). Naltrexone hydrochloride was purchased from Sigma Aldrich (St ...
-
bioRxiv - Cancer Biology 2020Quote: ... 6-Bnz-cAMP was purchased from Tocris Bioscience (5255) ...
-
bioRxiv - Neuroscience 2020Quote: ... 6-OHDA(100 mg/kg, Tocris, UK) was given every 2 d ...
-
bioRxiv - Cell Biology 2022Quote: ... 6 µM or 20 µM proTAME (Tocris) or 2 µM UMK57 or UMK95 during imaging ...
-
bioRxiv - Cell Biology 2023Quote: ... RAC1 inhibitor (CAS1177865-17-6; Tocris Biosciences) was used at 100 µM ...
-
bioRxiv - Neuroscience 2021Quote: ... and MNI-caged-L-glutamate ((S)-α-amino-2,3-dihydro-4-methoxy-7-nitro-δ-oxo-1H-indole-1-pentanoic acid) were purchased from Tocris (Bristol, UK). Rhod-2 tripotassium salt was purchased from AAT Bioquest (Sunnyvale ...
-
bioRxiv - Neuroscience 2022Quote: ... Animals were subsequently transferred to 1.5mL Lo-Bind tube and treated with 6-hydroxydopamine (6-OHDA; Tocris, Bristol, UK) containing 2mM ascorbic acid for one-hour ...
-
bioRxiv - Neuroscience 2020Quote: ... D-APV (50 μM; Tocris, Cat# 0106) synthetic Aβ1-42 (1.5 μM ...
-
bioRxiv - Neuroscience 2021Quote: ... d-amphetamine sulphate (2 mg/kg, Tocris), JZL184 (8 mg/kg ...
-
bioRxiv - Neuroscience 2021Quote: ... D-AP5 (Tocris Bioscience, 0106, 30 mM), an N-methyl-D-aspartate receptor blocker ...
-
bioRxiv - Neuroscience 2020Quote: ... D-AP5 (50 μM, NMDAR antagonist, Tocris), CGP 55845 were added into ACSF solution ...
-
bioRxiv - Neuroscience 2021Quote: ... and 50 D-APV (all from Tocris).
-
bioRxiv - Neuroscience 2020Quote: ... 100 μM D-APV (Tocris, Cat #0106) was added to the extracellular solution of both barrels to prevent the contribution of NMDA receptor currents ...
-
bioRxiv - Neuroscience 2021Quote: ... and 50 μM D-AP5 (Tocris #3693) for 2 minutes in conditioned medium ...
-
bioRxiv - Neuroscience 2021Quote: ... D-Glucose and NaCl) plus dorsomorphin (Tocris) every day over 2-3 weeks ...
-
bioRxiv - Immunology 2022Quote: ... Cytochalsin D (1233) was purchased from Tocris.
-
bioRxiv - Neuroscience 2022Quote: ... 50 μM D-APV (Tocris Cat#0106) was included in ACSF ...
-
bioRxiv - Neuroscience 2022Quote: ... and 0.1mM D-luciferin sodium salt (Tocris). 1µM VIP (Tocris ...
-
bioRxiv - Neuroscience 2023Quote: ... N-Methyl-D-Aspartate (NMDA, Tocris®). 7-(Hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester (CPCCOEt ...
-
bioRxiv - Cell Biology 2023Quote: ... and 100 μM D-AP5 (Tocris Biosciences), and a subset was also treated with 50 μM Thiamet-G ...
-
Astrocytic Neuroligins Are Not Required for Synapse Formation or a Normal Astrocyte CytoarchitecturebioRxiv - Neuroscience 2023Quote: ... 50 μM D-AP5 (Tocris, Cat. 0106), and 0.5 μM TTX ...
-
bioRxiv - Developmental Biology 2024Quote: ... 25 ng/mL rhEGF (R&D/Tocris), 0.8 mM Valproic Acid (Amsbio) ...
-
bioRxiv - Neuroscience 2020Quote: ... They were left drug-free for 3 weeks before chronic daily treatment with vehicle (NaCl 0.9%) or VU0155041 (Tocris, Bristol, UK; 2.5 or 5 mg/kg, i.p.) started ...
-
bioRxiv - Developmental Biology 2021Quote: ... (15) ESC were grown in N2B27 media supplemented with 2i/LIF (1 mM PD0325901, 3 mM CHIR99021, both from Tocris and 1:500 LIF, made in house). N2B27 media consisted of a 1:1 mix of DMEM/F12 and Neurobasal Medium ...
-
bioRxiv - Neuroscience 2019Quote: ... To block NMDA receptors we used D- (-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris, 10 μM final concentration). To block glycinergic inhibition ...
-
bioRxiv - Neuroscience 2020Quote: ... 20 μM 6,7-dinitroquinoxaline-2,3-dione (DNQX) and 20 μM D-(-)-2-amino-5-phosphopentanoic acid (D-AP5) (Tocris Bioscience) to block glycine- ...
-
bioRxiv - Biophysics 2021Quote: ... Cells were treated with 6 μM CHIR99021 (Tocris) for 48 hours on day 0 ...
-
bioRxiv - Developmental Biology 2021Quote: ... 6 μM Chir 99021 (Tocris cat. no. 4423), 20ng/ml murine bFGF (PeproTech cat ...